Regarding apoptosis, treatment with lenvatinib alone did not change the levels of cleaved caspase-3 and the mRNA expressions of apoptosis-related markers in liver cancer cells (Figure 1E,F and Supplementary Figure S1C). Here, CASP3 is linked to liver cancer.